相关实验视频
Updated: Jul 17, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
GDF-15和肝素作为慢性病中贫血的治疗点
Naglaa Makram Farag1, Mahmoud Mousa2, Eman Elsayed2
1Clinical Pathology, Minia University, Minia, Egypt. ahmedmohamedmostafa1971@yahoo.com.
增长差异化因子-15 (GDF-15) 和肝素显示出在患有慢性病 (CKD) 的埃及患者中诊断贫血的生物标志物的潜力. 这些标志物可以帮助预测贫血,特别是当与CKD中的炎症有关时.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 贫血是慢性病 (CKD) 患者的常见并发症,恶化了他们的预后.
- 在非透析的埃及CKD患者中,生长差异化因子-15 (GDF-15) 和肝素作为贫血生物标志物的实用性仍然不清楚.
研究的目的:
- 评估GDF-15和肝素在非透析的埃及慢性病患者的贫血诊断有效性.
- 评估这些生物标志物的预测价值,以确定该人群中的贫血.
主要方法:
- 一项分析横截面研究涉及60名非透析CKD患者和28名健康对照.
- 测量了GDF-15和肝素的血清水平. 进行了预测后勤回归和接收机操作员特征 (ROC) 分析.
主要成果:
- 与对照组相比,CKD患者的肝素和GDF-15水平显著更高 (p < 0.0001).
- 使用肝素和GDF-15诊断贫血的预测值分别为72.0%和70.0%.
- GDF-15与血红蛋白,费里丁,铁和C反应蛋白 (CRP) 有显著的相关性.
结论:
- 肝素和GDF-15是预测埃及CKD患者贫血的潜在生物标志物,特别是当与炎症相关时.
- 这些标志物可能有助于在这个脆弱的患者群体中早期诊断和治疗贫血.
更多相关视频
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention